DOT1L inhibition reprograms innate immunity to potentiate immunomodulatory drug responses in multiple myeloma

Authors:

Abstract
No abstract available
Funding Information
  • Northern Advancement Center for Science and Technology (2022)
  • Princess Takamatsu Cancer Research Fund
  • Japan Society for the Promotion of Science (22H02925)
  • Japan Society for the Promotion of Science (19K17836)
  • Japan Society for the Promotion of Science (23K24186)
  • Japan Society for the Promotion of Science (19H03518)
  • Japan Society for the Promotion of Science (23K15329)
  • Japan Society for the Promotion of Science (21K15556)
  • Akiyama Life Science Foundation (2023)